The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 30, 2013
Filed:
Aug. 23, 2011
Kate Ashton, Westlake Village, CA (US);
Michael David Bartberger, Sherman Oaks, CA (US);
Yunxin BO, Thousand Oaks, CA (US);
Marian C. Bryan, West Hills, CA (US);
Michael Croghan, Thousand Oaks, CA (US);
Christopher Harold Fotsch, Thousand Oaks, CA (US);
Clarence Henderson Hale, Camarillo, CA (US);
Roxanne Kay Kunz, Santa Monica, CA (US);
Longbin Liu, Thousand Oaks, CA (US);
Nobuko Nishimura, West Hills, CA (US);
Mark H. Norman, Thousand Oaks, CA (US);
Lewis Dale Pennington, Ventura, CA (US);
Steve Fong Poon, Woodland Hills, CA (US);
Markian Myroslaw Stec, Thousand Oaks, CA (US);
David Joseph St. Jean, Jr., Camarillo, CA (US);
Nuria A. Tamayo, Newbury Park, CA (US);
Christopher Michael Tegley, Thousand Oaks, CA (US);
Kevin Chao Yang, San Gabriel, CA (US);
Kate Ashton, Westlake Village, CA (US);
Michael David Bartberger, Sherman Oaks, CA (US);
Yunxin Bo, Thousand Oaks, CA (US);
Marian C. Bryan, West Hills, CA (US);
Michael Croghan, Thousand Oaks, CA (US);
Christopher Harold Fotsch, Thousand Oaks, CA (US);
Clarence Henderson Hale, Camarillo, CA (US);
Roxanne Kay Kunz, Santa Monica, CA (US);
Longbin Liu, Thousand Oaks, CA (US);
Nobuko Nishimura, West Hills, CA (US);
Mark H. Norman, Thousand Oaks, CA (US);
Lewis Dale Pennington, Ventura, CA (US);
Steve Fong Poon, Woodland Hills, CA (US);
Markian Myroslaw Stec, Thousand Oaks, CA (US);
David Joseph St. Jean, Jr., Camarillo, CA (US);
Nuria A. Tamayo, Newbury Park, CA (US);
Christopher Michael Tegley, Thousand Oaks, CA (US);
Kevin Chao Yang, San Gabriel, CA (US);
Amgen Inc., Thousand Oaks, CA (US);
Abstract
The present invention relates to compounds of Formula I, or pharmaceutically acceptable salts thereof, that interact with glucokinase regulatory protein. In addition, the present invention relates to methods of treating type 2 diabetes, and other diseases and/or conditions where glucokinase regulatory protein is involved using the compounds, or pharmaceutically acceptable salts thereof, and pharmaceutical compositions that contain the compounds, or pharmaceutically acceptable salts thereof.